Crowley John F's Form 4 filing

Amicus Therapeutics, Inc. (FOLD) · filed Apr 20, 2022

Accession no.: 0001209191-22-025052
Filed: Apr 20, 2022
Trade date: Apr 18-19, 2022
Filing delay: 2 days
Rule 10b5-1 plan: Not on the form (before 2023)

Original on SEC EDGAR (opens in a new tab)

This filing lists 2 non-derivative transactions. Open-market sales total $83.9K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
Owner	Relationship to the company
Crowley John FCIK 0001400973	Director, Officer (Chairman & CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade date	Security	Transaction	Shares	Price	Value	Shares after	Ownership	Flags
Apr 18, 2022	Common Stock	SSaleDisposed	−2,214	$8.04^F2	−$17,800.56	974,221	Direct
Apr 19, 2022	Common Stock	SSaleDisposed	−8,254	$8.01^F3	−$66,114.54	965,967	Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $8.00 to $8.15 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $8.00 to $8.03 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

Remarks

In addition to the reported transactions, Mr. Crowley also has approximately 462,000 options outstanding and exercisable at various strike prices.

Read the full filing on SEC EDGAR (opens in a new tab)